Mai-Britt Zocca is CEO at IO Biotech, Inc. (IOBT). They have made 1 open-market trade across 1 company since 2024, most recently 2024-12-23.
CIK 0001890736
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| IOBT | 49,891 | $2K |
Shares reported on the most recent Form 4, priced at the 2024-12-23 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IOBT | BUY | 2024-12-23 | 2024-12-23 | $0.81 | $10K | -0.2% | +0.0% | +11.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.